Managers Buy Out Qwest Online Pharmaceutical Marketing Practice

Share this article:
Senior managers have bought the online pharmaceutical marketing practice of Qwest Communications International Inc. in a buyout funded by Edison Venture Fund, Lawrenceville, NJ.


The practice will run under the name Cadient, operating from its current offices in Philadelphia and Malvern, PA. A staff of 40 managers and executives will retain their jobs. Terms of the buyout were not disclosed.


Cadient will continue to create online pharmaceutical programs for clients like Procter & Gamble Co., Johnson & Johnson, GlaxoSmithKline and AstraZeneca. Cadient programs focus on the behavior of consumers and doctors to persuade them to sample, buy, prescribe and stay loyal to prescription and over-the-counter pharmaceutical brands.


Cadient clients will continue to receive network services from Qwest. The online pharmaceutical practice divestiture is part of a Qwest initiative to exit areas not in its core communications services.


Established in 1986 and run by 15 investment professionals, Edison has 115 investments in expansion-stage, $5 million to $15 million, companies in the Mid-Atlantic region. Edison typically invests $3 million to $5 million, serving as the sole or lead investor.


This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions